↓ Skip to main content

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus long-acting beta2 -agonists for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
176 Dimensions

Readers on

mendeley
225 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus long-acting beta2 -agonists for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd006829.pub2
Pubmed ID
Authors

Luis Javier Nannini, Toby J Lasserson, Phillippa Poole

Abstract

Both inhaled steroids (ICS) and long-acting beta(2)-agonists (LABA) are used in the management of chronic obstructive pulmonary disease (COPD). This updated review compared compound LABA plus ICS therapy (LABA/ICS) with the LABA component drug given alone.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 1%
South Africa 1 <1%
Brazil 1 <1%
Australia 1 <1%
Russia 1 <1%
Unknown 218 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 19%
Researcher 33 15%
Student > Bachelor 27 12%
Student > Ph. D. Student 23 10%
Other 20 9%
Other 53 24%
Unknown 27 12%
Readers by discipline Count As %
Medicine and Dentistry 128 57%
Nursing and Health Professions 18 8%
Social Sciences 10 4%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Agricultural and Biological Sciences 6 3%
Other 20 9%
Unknown 34 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2020.
All research outputs
#1,323,507
of 15,839,236 outputs
Outputs from Cochrane database of systematic reviews
#3,510
of 11,299 outputs
Outputs of similar age
#11,760
of 150,414 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 88 outputs
Altmetric has tracked 15,839,236 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,299 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,414 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.